Frankfurt - Delayed Quote EUR

Dassault Systèmes SE (DSYA.F)

33.69

-0.31

(-0.91%)

As of 8:09:21 AM GMT+1. Market Open.

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of December 31, 2024

Press ReleaseVELIZY-VILLACOUBLAY, France — January 8, 2025 Declaration of the number of outstanding shares and voting rights as of December 31, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of December 31, 2024, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,339,674,751 Number of voting rights*: 2,013,219,4

GlobeNewswire 4 days ago

DASTF

DASTY
Dassault Systèmes : Half-year statement of the Liquidity contract entered into with Oddo BHF SCA

Press ReleaseVELIZY-VILLACOUBLAY, France — January 6, 2025 Half-year statement of the Liquidity contract entered into with Oddo BHF SCA Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) announces that the following resources appeared on December 31, 2024 on the liquidity contract entered into with Oddo BHF SCA implemented on January 7, 2015 and updated on June 18, 2019: 671,015.00 Dassault Systèmes shares, and€ 11,139,634.13 in cash. It is reminded that: 1. at the time of the implementati

GlobeNewswire 7 days ago

DASTF

DASTY
ClinChoice Extends 13-Year Medidata Partnership with the Addition of Clinical Data Studio to Improve Data Management and Strengthen Clinical Trial Capabilities

NEW YORK, December 18, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has renewed its long-standing enterprise partnership with ClinChoice, a global contract research organization (CRO). Under this new agreement, ClinChoice will utilize the Medidata Platform to streamline study data and supply management, boost trial efficiency, and accelerate growth as a full-service CRO in Asia, Europe, and North America. ClinChoice als

Business Wire 25 days ago

DASTF

DASTY
Dassault Systèmes: Electrical Grid Operator Red Eléctrica Transforms Its Design Process and Collaboration with Dassault Systèmes’ 3DEXPERIENCE Platform

Press ReleaseVELIZY-VILLACOUBLAY, France — December 11, 2024 Electrical Grid Operator Red Eléctrica Transforms Its Design Process and Collaboration with Dassault Systèmes’ 3DEXPERIENCE Platform Spain’s transmission system operator will use Dassault Systèmes’ 3DEXPERIENCE platform on the cloud to coordinate the design of the smart grid energy network More than 1,500 users will be connected via a “multiscale” virtual twin to visualize the electrical asset ecosystem Cloud-based collaboration and a

GlobeNewswire last month

DASTF

DASTY
Electrical Grid Operator Red Eléctrica Transforms Its Design Process and Collaboration with Dassault Systèmes’ 3DEXPERIENCE Platform

VELIZY-VILLACOUBLAY, France, December 11, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Red Eléctrica, the transmission system operator (TSO) of Spain’s high voltage electricity system, has selected, after a competitive process, Dassault Systèmes’ 3DEXPERIENCE platform on the cloud to support processes that manage the technical asset information of Spain’s electricity network.

Business Wire last month

DASTF

DASTY
Dassault Systèmes and UniLaSalle Combine Learning and Exploring with Virtual Worlds in New 3DEXPERIENCE Edu Center of Excellence

VELIZY-VILLACOUBLAY, France & BEAUVAIS, France, December 10, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and UniLaSalle, an engineering university in France focused on life, digital, energy and veterinary sciences, today announced that UniLaSalle has become the 25th member of the 3DEXPERIENCE Edu Center of Excellence global program, which provides experiential, lifelong learning with Dassault Systèmes’ 3DEXPERIENCE platform to accelerate the digital transformation of industry.

Business Wire last month

DASTF

DASTY
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of November 30, 2024

Press ReleaseVELIZY-VILLACOUBLAY, France — December 4, 2024 Declaration of the number of outstanding shares and voting rights as of November 30, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of November 30, 2024, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,339,494,748 Number of voting rights*: 2,013,134,

GlobeNewswire last month

DASTF

DASTY
Medical firms urged not to let assumptions put patients at risk

At the11th annual Clinical Trials in Oncology conference, healthcare companies were urged to keep rigorous records during clinical trials to ensure patient safety.

Clinical Trials Arena last month

DSY.PA
HSBC downgrades Autodesk on moderating earnings growth, valuation concerns

Investing.com -- HSBC downgraded Autodesk Inc (NASDAQ:ADSK) to “hold” from “buy” as it expects moderating earnings growth and valuation concerns relative to peer Dassault Systèmes. Brokerage also lowered its target price on the stock by $9 to $290.

Investing.com last month

ADSK

DSY.PA
Dassault Systèmes’ 3DEXPERIENCE Platform to Be Used for Electric Vehicle Development at Volvo Cars

VELIZY-VILLACOUBLAY, France, November 14, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Volvo Cars has chosen to deploy Dassault Systèmes’ 3DEXPERIENCE platform within its engineering processes for vehicle development.

Business Wire last month

DASTF

DASTY
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment

NEW YORK, November 13, 2024--Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a leader in Everest Group's first-ever Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment 2024. The report assessed 13 providers based on the market impact of their products and their ability to deliver successful, high-quality offerings.

Business Wire last month

DASTF

DASTY
Medidata Unveils Transformative Solutions and Collaborations at NEXT New York, Driving Paradigm Shift in Life Sciences and Healthcare

NEW YORK, November 13, 2024--Medidata, a Dassault Systèmes brand and leader of clinical trial solutions to the life sciences industry, is kicking off NEXT New York 2024, its premier life sciences conference. Uniting more than 1,000 healthcare customers and partners, the event will showcase AI-powered innovations that accelerate clinical trials, streamline data management, and enhance decision-making for life-saving therapies.

Business Wire last month

DASTF

DASTY
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials

LONDON, November 12, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new enterprise agreement with Bioforum, a biometrics CRO that serves clinical trial sponsors worldwide.

Business Wire last month

DASTF

DASTY
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of October 31, 2024

Press ReleaseVELIZY-VILLACOUBLAY, France — November 7, 2024 Declaration of the number of outstanding shares and voting rights as of October 31, 2024 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of October 31, 2024, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,339,460,603 Number of voting rights*: 2,013,203,69

GlobeNewswire 2 months ago

DASTF

DASTY
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution

NEW YORK, October 31, 2024--Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive trial designs, and trial diversity. By unifying key trial components such as real-time patient-reported outcomes and imaging m

Business Wire 2 months ago

DASTF

DASTY
Dassault Systèmes Collaboration Yields Breakthrough Guide for Using Virtual Twins in Clinical Trials

VELIZY-VILLACOUBLAY, France, October 30, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced the availability of the world’s first guide for the medical device industry that outlines how to use virtual twins to accelerate clinical trials. This guide was published following the successful completion of a five-year collaboration with the U.S. Food and Drug Administration. The in silico clinical trial "ENRICHMENT Playbook" marks a significant advancement in the integratio

Business Wire 2 months ago

DASTF

DASTY
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics

NEW YORK, October 29, 2024--Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, today announced a partnership with neuroscience solutions leader Cogstate to reshape clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders, among others.

Business Wire 2 months ago

DASTF

DASTY

COGZF
Dassault Systèmes’ 3DEXPERIENCE Platform Recognized as PACT Conformant, Unlocking Decarbonization in the Value Chain

VELIZY-VILLACOUBLAY, France, October 29, 2024--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that the 3DEXPERIENCE platform is now listed as a PACT conformant solution by the World Business Council for Sustainable Development Partnership for Carbon Transparency, the global standard for calculating and exchanging Scope 3 greenhouse gas data across the value chain. This recognition helps Dassault Systèmes’ customers and their value chains make smart, carbon-informed busi

Business Wire 2 months ago

DASTF

DASTY
Dassault Systemes SE (DASTF) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Market ...

Despite headwinds in the automotive sector, Dassault Systemes SE (DASTF) reports solid subscription growth and maintains strong performance in key industries.

GuruFocus.com 2 months ago

DSY.PA
Dassault Systemes Cuts Guidance After Revenue, Operating Profit Disappoint

The French software maker lowered its guidance for the year after revenue and operating profit came in shy of analyst expectations in the third quarter.

The Wall Street Journal 2 months ago

DASTF

DASTY

Performance Overview

Return	DSYA.F	CAC 40
YTD	+2.25%	+1.02%
1-Year	-22.54%	-1.03%
3-Year	-27.47%	+2.09%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Dassault Systèmes SE (DSYA.F)

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of December 31, 2024

Dassault Systèmes : Half-year statement of the Liquidity contract entered into with Oddo BHF SCA

ClinChoice Extends 13-Year Medidata Partnership with the Addition of Clinical Data Studio to Improve Data Management and Strengthen Clinical Trial Capabilities

Dassault Systèmes: Electrical Grid Operator Red Eléctrica Transforms Its Design Process and Collaboration with Dassault Systèmes’ 3DEXPERIENCE Platform

Electrical Grid Operator Red Eléctrica Transforms Its Design Process and Collaboration with Dassault Systèmes’ 3DEXPERIENCE Platform

Dassault Systèmes and UniLaSalle Combine Learning and Exploring with Virtual Worlds in New 3DEXPERIENCE Edu Center of Excellence

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of November 30, 2024

Medical firms urged not to let assumptions put patients at risk

HSBC downgrades Autodesk on moderating earnings growth, valuation concerns

Dassault Systèmes’ 3DEXPERIENCE Platform to Be Used for Electric Vehicle Development at Volvo Cars

Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment

Medidata Unveils Transformative Solutions and Collaborations at NEXT New York, Driving Paradigm Shift in Life Sciences and Healthcare

Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of October 31, 2024

Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution

Dassault Systèmes Collaboration Yields Breakthrough Guide for Using Virtual Twins in Clinical Trials

Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics

Dassault Systèmes’ 3DEXPERIENCE Platform Recognized as PACT Conformant, Unlocking Decarbonization in the Value Chain

Dassault Systemes SE (DASTF) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Market ...

Dassault Systemes Cuts Guidance After Revenue, Operating Profit Disappoint

Performance Overview